Conditioned blood reperfusion markedly enhances neurologic recovery after prolonged cerebral ischemia.

[1]  G. Buckberg,et al.  Deep hypothermic circulatory arrest and global reperfusion injury: avoidance by making a pump prime reperfusate--a new concept. , 2003, The Journal of thoracic and cardiovascular surgery.

[2]  B. Allen.  The role of leukodepletion in limiting ischemia/reperfusion damage in the heart, lung and lower extremity , 2002, Perfusion.

[3]  D. Wypij,et al.  Developmental and neurologic effects of alpha-stat versus pH-stat strategies for deep hypothermic cardiopulmonary bypass in infants. , 2001, The Journal of thoracic and cardiovascular surgery.

[4]  Jeffrey A. Golden,et al.  Comparison of neurologic outcome after deep hypothermic circulatory arrest with alpha-stat and pH-stat cardiopulmonary bypass in newborn pigs. , 2001, The Journal of thoracic and cardiovascular surgery.

[5]  James L. Park,et al.  Conditioned blood reperfusion during angioplasty (CoBRA) treatment of acute myocardial infarction , 2001, Perfusion.

[6]  B. Allen,et al.  Hypoxia, reoxygenation and the role of systemic leukodepletion in pediatric heart surgery , 2001, Perfusion.

[7]  V. Vainionpää,et al.  Leukocyte filtration improves brain protection after a prolonged period of hypothermic circulatory arrest: A study in a chronic porcine model. , 2000, The Journal of thoracic and cardiovascular surgery.

[8]  B. Allen,et al.  Reducing postischemic reperfusion damage in neonates using a terminal warm substrate-enriched blood cardioplegic reperfusate. , 2000, The Annals of thoracic surgery.

[9]  B. Allen,et al.  L-arginine, prostaglandin, and white cell filtration equally improve myocardial protection in stressed neonatal hearts. , 1999, The Journal of thoracic and cardiovascular surgery.

[10]  J. Bucerius,et al.  Oxygenation strategy and neurologic damage after deep hypothermic circulatory arrest. II. hypoxic versus free radical injury. , 1999, The Journal of thoracic and cardiovascular surgery.

[11]  A. M. Lefer,et al.  Synergism between platelets and neutrophils in provoking cardiac dysfunction after ischemia and reperfusion: role of selectins. , 1998, Circulation.

[12]  B. Allen,et al.  Controlled reperfusion prevents pulmonary injury after 24 hours of lung preservation. , 1998, The Annals of thoracic surgery.

[13]  H. Darius,et al.  Blocking of classical complement pathway inhibits endothelial adhesion molecule expression and preserves ischemic myocardium from reperfusion injury. , 1998, The Journal of pharmacology and experimental therapeutics.

[14]  L. Matis,et al.  Myocardial infarction and apoptosis after myocardial ischemia and reperfusion: role of the terminal complement components and inhibition by anti-C5 therapy. , 1998, Circulation.

[15]  M. Ovize,et al.  A fresh look at reperfusion injury. , 1998, Cardiovascular research.

[16]  B. Allen,et al.  Controlled reperfusion after lung ischemia: implications for improved function after lung transplantation. , 1998, The Journal of thoracic and cardiovascular surgery.

[17]  B. Allen,et al.  Detrimental effects of cardiopulmonary bypass in cyanotic infants: preventing the reoxygenation injury. , 1997, The Annals of thoracic surgery.

[18]  E. Verrier,et al.  Ischemia-Reperfusion Injury , 1997 .

[19]  D. Taggart.  Leukocyte and platelet depletion with a blood cell separator. , 1996, The Journal of thoracic and cardiovascular surgery.

[20]  W. van Oeveren,et al.  Leukocyte depletion results in improved lung function and reduced inflammatory response after cardiac surgery. , 1996, The Journal of thoracic and cardiovascular surgery.

[21]  G. Buckberg,et al.  Controlled limb reperfusion in patients having cardiac operations. , 1996, The Journal of thoracic and cardiovascular surgery.

[22]  T. Miura,et al.  University of Wisconsin cerebroplegia in a piglet survival model of circulatory arrest. , 1995, The Annals of thoracic surgery.

[23]  G. Buckberg,et al.  Studies of hypoxemic/reoxygenation injury: without aortic clamping. III. Comparison of the magnitude of damage by hypoxemia/reoxygenation versus ischemia/reperfusion. , 1995, The Journal of thoracic and cardiovascular surgery.

[24]  G. Buckberg.  Studies of hypoxemic/reoxygenation injury: I. Linkage between cardiac function and oxidant damage. , 1995, The Journal of thoracic and cardiovascular surgery.

[25]  L. Matis,et al.  Blockade of C5a and C5b-9 generation inhibits leukocyte and platelet activation during extracorporeal circulation. , 1995, The Journal of clinical investigation.

[26]  A. Agostoni,et al.  Complement system in coronary heart disease: a review. , 1995, Immunopharmacology.

[27]  A. Castañeda.  Cardiac Surgery of the Neonate and Infant , 1994 .

[28]  A. Hawes,et al.  Platelet-activating factor antagonism attenuates platelet and neutrophil activation and reduces myocardial injury during coronary reperfusion. , 1993, The Journal of surgical research.

[29]  G. Buckberg,et al.  Immediate functional recovery after six hours of regional ischemia by careful control of conditions of reperfusion and composition of reperfusate. , 1986, The Journal of thoracic and cardiovascular surgery.

[30]  B. Allen,et al.  Pediatric myocardial protection: an overview. , 2001, Seminars in thoracic and cardiovascular surgery.

[31]  R. Muraoka,et al.  Effects of depletion of leukocytes and platelets on cardiac dysfunction after cardiopulmonary bypass. , 1998, The Annals of thoracic surgery.

[32]  森岡浩一.  LEUKOCYTE AND PLATELET DEPLETION WITH A BLOOD CELL SEPARATOR: EFFECTS ON LUNG INJURY AFTER CARDIAC SURGERY WITH CARDIOPULMONARY BYPASS(体外循環下開心術後の肺の障害に対する血球分離装置を用いた白血球・血小板除去の効果) , 1997 .

[33]  M. Thoresen,et al.  The piglet as a model for cerebral circulation: an angiographic study. , 1995, Biology of the neonate.

[34]  M. Cambillau,et al.  Improvement of postischemic kidney function by reperfusion with a specifically developed solution (BT01). , 1995, Annals of vascular surgery.

[35]  B. Smith,et al.  Platelet-leukocyte activation and modulation of adhesion receptors in pediatric patients with congenital heart disease undergoing cardiopulmonary bypass. , 1994, The Journal of thoracic and cardiovascular surgery.

[36]  L. Cohn,et al.  Controlled reperfusion of the regionally ischemic myocardium with leukocyte-depleted blood reduces stunning, the no-reflow phenomenon, and infarct size. , 1992, The Journal of thoracic and cardiovascular surgery.

[37]  A. Baue,et al.  Glenn's Thoracic and Cardiovascular Surgery , 1991 .